Published in J Thromb Thrombolysis on August 01, 2006
Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients. BMC Nephrol (2011) 0.83
Attitudes and preferences on the use of mobile health technology and health games for self-management: interviews with older adults on anticoagulation therapy. JMIR Mhealth Uhealth (2014) 0.82
Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum. Ann Pharmacother (2013) 0.76
Feasibility of ASsisTed WARfarin Dosing by Clinical Pharmacy Support Assistants (FAST-WARD Study). Can J Hosp Pharm (2014) 0.75
Advantages of a Warfarin Protocol for Long-term Care Pharmacists: a Retrospective Cohort Study. Can Geriatr J (2016) 0.75
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol (2002) 3.79
Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation (2006) 2.68
Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques. Circulation (2005) 2.01
Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol (2007) 1.82
Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol (2008) 1.43
Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol (2005) 1.37
Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation (2002) 1.32
Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities. J Cardiovasc Pharmacol Ther (2011) 1.24
Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal (2010) 1.17
Authorship and characteristics of articles in pharmacy journals: changes over a 20-year interval. Ann Pharmacother (2011) 1.17
Cardioprotection 'outside the box'--the evolving paradigm of remote preconditioning. Basic Res Cardiol (2003) 1.15
Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair. J Am Coll Cardiol (2006) 1.08
Autophagy as a therapeutic target for ischaemia /reperfusion injury? Concepts, controversies, and challenges. Cardiovasc Res (2012) 1.04
Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. Lab Invest (2009) 1.01
Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic. J Manag Care Pharm (2011) 1.00
Adaptation of a photochemical method to initiate recurrent platelet-mediated thrombosis in small animals. Lasers Med Sci (2007) 0.93
Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic. J Thromb Thrombolysis (2010) 0.92
The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol (2002) 0.92
Lamina propria cellularity and collagen composition: an integrated assessment of structure in humans. Ann Otol Rhinol Laryngol (2009) 0.89
Venous thromboembolism in an industrial north american city: temporal distribution and association with particulate matter air pollution. PLoS One (2013) 0.84
Collagen fiber morphology determines echogenicity of myocardial scar: implications for image interpretation. Echocardiography (2006) 0.83
Genesis of remote conditioning: action at a distance--'hypotheses non fingo'? J Cardiovasc Med (Hagerstown) (2013) 0.83
Myocardial infarction in an adolescent taking Adderall. Am J Health Syst Pharm (2005) 0.82
In vitro platelet responsiveness to adenosine-mediated "preconditioning" is age-dependent. J Thromb Thrombolysis (2005) 0.81
First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning. Am J Physiol Heart Circ Physiol (2006) 0.81
The effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapy. Drugs Aging (2012) 0.81
Pretreatment with D-myo-inositol trisphosphate reduces infarct size in rabbit hearts: role of inositol trisphosphate receptors and gap junctions in triggering protection. J Pharmacol Exp Ther (2005) 0.81
Cardioprotection via adaptation to hypoxia: expanding the timeline and targets? Basic Res Cardiol (2011) 0.79
Cardioprotection with adenosine: 'a riddle wrapped in a mystery'. Br J Pharmacol (2005) 0.79
Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol (2005) 0.79
Hypoechoic areas on ultrasound images of atheroma are not always diagnostic of fatty plaque. Ultrasound Med Biol (2005) 0.78
Kidney dysfunction at the time of intracerebral hemorrhage is associated with increased in-hospital mortality: a retrospective observational cohort study. Neurol Res (2012) 0.77
Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists. J Manag Care Pharm (2007) 0.76
Warfarin maintenance dose in older patients: higher average dose and wider dose frequency distribution in patients of African ancestry than those of European ancestry. Blood Cells Mol Dis (2010) 0.76
Remote ischemic conditioning and renal function after contrast-enhanced CT scan: A randomized trial. Clin Invest Med (2015) 0.76
Point-of-care assessment of platelet reactivity in the emergency department may facilitate rapid rule-out of acute coronary syndromes: a prospective cohort pilot feasibility study. BMJ Open (2014) 0.75
How one academic medical center has managed potency changes with unfractionated heparin. J Thromb Thrombolysis (2013) 0.75
Lepirudin-induced thrombocytopenia following subcutaneous administration. Am J Health Syst Pharm (2009) 0.75
An overview of heparin-induced thrombocytopenia. J Pharm Pract (2010) 0.75
A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux. J Thromb Thrombolysis (2012) 0.75
Ventricular remodeling after myocardial infarction and effects of ACE inhibition on hemodynamics and scar formation in SHR. Cardiovasc Pathol (2002) 0.75
Brief apnea induces myocardial ischemic tolerance by an opioid-insensitive mechanism. Cardiovasc Pathol (2004) 0.75